Helping Create a Healthier World

Renee A Butler in Pharm-Olam

May 5, 2021

Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time…

Renee A Butler in Pharm-Olam

Mar 17, 2021

8 Strategies for Navigating Clinical Studies During COVID-19 | Pharm-Olam

5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials

Renee A Butler in Pharm-Olam

Nov 25, 2020

Understanding the 3 Types of Clinical Trial Monitoring

1 response

Renee A Butler in Pharm-Olam

Nov 11, 2020

Completing a Rescue Study Transition — How Much Time Do You Need?

Renee A Butler in Pharm-Olam

Nov 4, 2020

Effective Cohort Management in Early Phase Oncology Trials

About

Pharm-Olam

Pharm-Olam is a global clinical research organization (CRO) delivering clinical trial services to pharmaceutical, biotechnology, government, and public health organizations developing small molecule, biologics, and vaccines.

More information

Followers

Elsewhere

Recent Milestones in Rare Cancer Research

8 Strategies for Navigating Clinical Studies During COVID-19 | Pharm-Olam

COVID-19 has presented a…

Risk Management: Foundation for Better Project Management | Pharm-Olam

What is the Difference Between Microbiome and Microbiota?

Understanding the Connection Between COVID-19 and VAP

Importance of Natural History Study to Rare Disease Drug Development

5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials

Understanding the 3 Types of Clinical Trial Monitoring

Completing a Rescue Study Transition — How Much Time Do You Need?

Effective Cohort Management in Early Phase Oncology Trials